Olema Pharmaceuticals, Inc. (NASDAQ: OLMA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT OLEMA PHARMACEUTICALS, INC.

Olema Pharmaceuticals, Inc. (NASDAQ: OLMA)
Listen to this Section


$9.88
-0.0050 ( -0.05% ) 5.8K

Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.

Market Data


Open $9.88
Previous Close $9.88
Volume 5.8K
Market Cap $862.99M
Day Range $9.86 - $10.29
52 Week Range $3.90 - $36.26
Shares Outstanding 87.35M
Change % -0.05%
Net Change ▼ -0.0050
Insider Ownership -0.48%
Exchange NASDAQ
SectorMiscellaneous
IndustryNone
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -2,014,565.00

Date Type Amount Purchased Purchaser
2024-08-05 Sale -1870499.00 Paradigm Biocapital Advisors LP
2024-07-31 Sale -4066.00 Harmon Cyrus
2024-07-12 Sale -5000.00 Harmon Cyrus
2024-07-02 Sale -20000.00 Harmon Cyrus
2024-06-18 Sale -23000.00 BVF PARTNERS L P/IL
2024-06-18 Sale -23000.00 Harmon Cyrus
2024-06-18 Sale -23000.00 Horning Sandra
2024-06-18 Sale -23000.00 RAPPAPORT ANDREW
2024-06-18 Sale -23000.00 Graham G. Walmsley

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025
8-k 8K-related 10 Jun 13, 2025
4 Insider transactions 1 Jun 13, 2025

Latest News


× Before browsing our site, please accept our cookies policy